Warning letter
Innovatech Medical Resources L.P. d/b/a Medical Services International (MSI): warning letter of Feb 23, 2012
FDA warning letter 264416 · Dallas District Office
Key facts
| Reference number | 264416 |
|---|---|
| Company | Innovatech Medical Resources L.P. d/b/a Medical Services International (MSI) |
| Subject | CGMP/QSR/Medical Devices/Adulterated |
| Issue date | Feb 23, 2012 |
| Posted date | Feb 23, 2012 |
| Issuing office | Dallas District Office |
| Product type | Devices |
| CFR sections cited | 803, 803.3, 803.17, 806, 820, 806.10(b) |
| Inspection city | Midlothian |
| Inspection ZIP | 76065 |
| Inspection start date | Sep 15, 2011 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: